Chin Liong Tan1*, Muhamad Ameer Fikri Zaidi1, Mohd Safwan Zahar1, Nur Azrenawaty Mohd Nor1, Mohamad Nadzmi Md Nadzri2, Muhammad Afif Azizan1, Rozainanee Mohd Zain1
1. Virology Unit, Infectious Disease Research Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170 Shah Alam, Selangor, Malaysia
2. Biomedical Epidemiology Unit, Special Resource Centre, Institute for Medical Research, National Institutes of Health, Ministry of Health Malaysia, Setia Alam, 40170 Shah Alam, Selangor, Malaysia
*Corresponding author: Tan Chin Liong.
ABSTRACT
INTRODUCTION: The ongoing COVID-19 pandemic has resulted in a significant rise in out-of-hospital deaths, often classified as brought-in-dead (BID) cases. While COVID-19 is frequently listed as the main cause of death, the potential role of concurrent respiratory bacterial and viral coinfections in these BID cases remains insufficiently explored. Understanding the prevalence and effects of such coinfections is essential for accurately evaluating the multifactorial aspects of COVID-19-related mortality.
OBJECTIVE(S): We aimed to investigate the detection rate of respiratory bacterial and viral coinfections in COVID-19 BID cases, using a multiplex PCR platform encompassing a wide range of common respiratory pathogens.
MATERIALS & METHODS: We retrospectively examined post-mortem lower respiratory tract specimens (bronchial, tracheal, or lung swabs or lung tissues) from 334 COVID-19 positive BID cases submitted to the Virology Unit, Institute for Medical Research (IMR), Malaysia in 2022 for the presence of respiratory bacterial and viral co-pathogens using the BioFire FilmArray Pneumonia Panel plus (Pneumoplus) and Respiratory Panel 2.1plus assays (bioMérieux, USA), following the manufacturer’s instructions.
RESULTS: Among the COVID-19-positive BID cases, 91.0% (304/334) had bacterial coinfections, and 9.0% (30/334) had viral coinfections. The predominant bacterial co-pathogens identified were the Enterobacter cloacae complex (60.5%, n = 184) and the Klebsiella pneumoniae group (58.9%, n = 179). The most common viral co-pathogens were human rhinovirus/enterovirus (43.3%, n = 13), adenovirus (33.3%, n = 10), influenza A virus (16.7%, n = 5), and parainfluenza virus (16.7%, n = 5). No atypical bacteria were detected.
CONCLUSION: Our findings revealed a remarkably high prevalence of respiratory coinfections among COVID-19-positive BID cases. Comprehensive post-mortem screening for respiratory co-pathogens is crucial for improving the understanding of the multifactorial causes of mortality in COVID-19, thereby guiding future public health strategies and forensic investigations.
KEYWORDS: Respiratory Coinfections, COVID-19, Post-mortem, Forensic, Brought-in-dead


